An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis
Background: Sepsis is a syndrome characterised by a systemic inflammatory response to infection that leads to rapid acute organ failure and potentially rapid decline to death. Intravenous immunoglobulin (IVIG), a blood product derived from human donor blood, has been proposed as an adjuvant therapy...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
NIHR Journals Library
2012-02-01
|
| シリーズ: | Health Technology Assessment |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.3310/hta16070 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|